HighTower Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-57,988
| Closed | -$2.36M | – | 3622 |
|
|
2024
Q2 | $2.36M | Sell |
57,988
-4,088
| -7% | -$166K | ﹤0.01% | 1357 |
|
|
2024
Q1 | $2.62M | Sell |
62,076
-1,000
| -2% | -$42.1K | ﹤0.01% | 1297 |
|
|
2023
Q4 | $2.66M | Sell |
63,076
-11,212
| -15% | -$473K | ﹤0.01% | 1279 |
|
|
2023
Q3 | $1.63M | Buy |
74,288
+250
| +0.3% | +$5.47K | ﹤0.01% | 1482 |
|
|
2023
Q2 | $2.36M | Sell |
74,038
-500
| -0.7% | -$15.9K | ﹤0.01% | 1254 |
|
|
2023
Q1 | $1.81M | Sell |
74,538
-500
| -0.7% | -$12.1K | ﹤0.01% | 1343 |
|
|
2022
Q4 | $2.38M | Sell |
75,038
-30
| -0% | -$950 | 0.01% | 1192 |
|
|
2022
Q3 | $2.12M | Sell |
75,068
-500
| -0.7% | -$14.1K | 0.01% | 1198 |
|
|
2022
Q2 | $1.99M | Sell |
75,568
-600
| -0.8% | -$15.8K | 0.01% | 1253 |
|
|
2022
Q1 | $2.69M | Buy |
76,168
+2,680
| +4% | +$94.6K | 0.01% | 1206 |
|
|
2021
Q4 | $2.37M | Buy |
73,488
+1,644
| +2% | +$53K | 0.01% | 1262 |
|
|
2021
Q3 | $2.13M | Hold |
71,844
| – | – | 0.01% | 1214 |
|
|
2021
Q2 | $1.85M | Buy |
71,844
+5,300
| +8% | +$136K | 0.01% | 1266 |
|
|
2021
Q1 | $914K | Buy |
66,544
+21,219
| +47% | +$291K | ﹤0.01% | 1623 |
|
|
2020
Q4 | $752K | Buy |
+45,325
| New | +$752K | ﹤0.01% | 1410 |
|